IP Library Granted Patent US 7,888,061
Granted Patent B2
US 7,888,061 · App. 11/434,251 · Granted Feb 15, 2011

Method of stabilising or reactivating a creatinine sensor with a divalent manganese ion

Assignee: Radiometer Medical ApS
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,888,061
App. No.
11/434,251
Granted
Feb 15, 2011
Kind
B2
Abstract

A method is provided for stabilizing a creatinine sensor comprising creatininase as a bioactive molecule. The creatininase is stabilised by exposing it to a sufficient amount of a divalent manganese ion. This result may be obtained by exposing the sensor to a solution comprising the divalent manganese ion or by introducing a composition within the sensor providing sustained release of the divalent manganese ion.

Claims (13)

1. A method of stabilising or reactivating a creatinine sensor comprising creatininase as a bioactive molecule, comprising exposing the creatininase to an amount of a solution of a divalent manganese ion sufficient to increase the stability or to increase the activity of the sensor,

wherein the solution comprises the divalent manganese ion in a concentration of in the range of about 2 to about 10 μM,

wherein the creatininase is exposed to the solution of the divalent manganese ion for at least about 50% of the time, and

wherein the sensor is arranged in a multi-sensor array.

2. The method according to claim 1 , wherein the creatininase is exposed to the amount of the divalent manganese ion by conveying the solution comprising the divalent manganese ion to the creatininase.

3. The method according to claim 1 , wherein the solution is prepared by passing a suitable liquid over a filter comprising a composition that releases the divalent manganese ion for a sustained period of time prior to exposing the creatininase to the solution.

4. The method according to claim 1 , wherein the amount of the divalent manganese ion is prepared as a solution by contacting a suitable liquid with a composition present within the sensor that releases the divalent manganese ion for a sustained period of time and then exposing the solution to the creatininase.

5. The method according to claim 3 or claim 4 , wherein the composition comprises a sparingly soluble salt of the divalent manganese ion.

6. The method according to claim 5 , wherein the sparingly soluble salt of the divalent manganese ion is selected from the group consisting of carbonate, citrate, tartrate, oxalate, orthophosphate, selenide, sulphide, hydroxide, oxalate, orthophosphate, selenite, and mixtures thereof.

7. The method according to claim 6 , wherein the sparingly soluble salt is selected from the group consisting of carbonate, citrate, and tartrate.

8. The method according to claim 1 , wherein the creatininase is further exposed to a solution comprising a cation complexing agent.

9. The method according to claim 8 , wherein the cation complexing agent is ethylenediamine tetraacetic acid (EDTA).

10. The method according to claim 8 or claim 9 , wherein the concentration of the cation complexing agent is in the range of about 1 to about 4 μM.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2014
From: RADIOMETER APS
To: RADIOMETER MEDICAL APS
Reel/Frame 031985/0034 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2006
From: KJAER, THOMAS; OSTERGAARD, JENS; KRISTENSEN, TINA
To: RADIOMETER MEDICAL APS
Reel/Frame 018068/0182 →
Continuity (2)
Provisional Application 60697360 · Jul 8, 2005
Related Publication 20060275860A1 · Dec 7, 2006